SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-311150
Filing Date
2011-11-14
Accepted
2011-11-14 16:44:47
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d227347d10q.htm 10-Q 865683
2 SECTION 302 CEO CERTIFICATION d227347dex311.htm EX-31.1 6087
3 SECTION 302 CFO CERTIFICATION d227347dex312.htm EX-31.2 6153
4 SECTION 906 CEO AND CFO CERTIFICATION d227347dex321.htm EX-32.1 5477
  Complete submission text file 0001193125-11-311150.txt   3078002

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT abio-20110930.xml EX-101.INS 333840
6 XBRL TAXONOMY EXTENSION SCHEMA abio-20110930.xsd EX-101.SCH 20343
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20110930_cal.xml EX-101.CAL 39146
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20110930_def.xml EX-101.DEF 67628
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20110930_lab.xml EX-101.LAB 182536
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20110930_pre.xml EX-101.PRE 131429
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 111203541
SIC: 2835 In Vitro & In Vivo Diagnostic Substances